Glycemic control is related to the severity of impaired thermal sensations in type 2 diabetes

Diabetes/Metabolism Research and Reviews

Volumn 23, Issue 8, 2007, Pages 612-620

  Chao, Chi Chao ^a   Hsieh, Song Chou ^a   Yang, Wei Shiung ^a   Lin, Yea Hui ^a   Lin, Whei Min ^b   Tai, Tong Yuan ^a   Hsieh, Sung Tsang ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Nerve conduction studies; Quantitative sensory testing; Sensory neuropathy; Sensory thresholds; Small fibre neuropathy; Thermal thresholds

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ABNORMAL SENSATION; ADULT; AGE DISTRIBUTION; AGED; ARM DISEASE; ARTICLE; COLD SENSATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEUROPATHY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; FOOT DISEASE; GLYCEMIC CONTROL; HEAT SENSATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NERVE CELL MEMBRANE POTENTIAL; NERVE CONDUCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCEPTIVE THRESHOLD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SENSORY ANALYSIS; SENSORY NERVE; SEX DIFFERENCE; SURAL NERVE;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FINGERS; FOOT; HEAT; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MEDIAN NERVE; MIDDLE AGED; NEURAL CONDUCTION; PERONEAL NERVE; REFERENCE VALUES; SENSORY THRESHOLDS; SURAL NERVE; TOES;

EID: 36749096903     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.734     Document Type: Article

References (39)

1. Adler AI, Boyko EJ, Ahroni JH, Smith DG. Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diabetes Care 1999; 22: 1029-1035.
2. Jeffcoate WJ, Price P, Harding KG. Wound healing and treatments for people with diabetic foot ulcers. Diabetes Metab Res Rev 2004; 20(Suppl. 1): S78-S89.
3. McNeely MJ, Boyko EJ, Ahroni JH, et al. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks? Diabetes Care 1995; 18: 216-219.
4. Albers JW, Brown MB, Sima AA, Greene DA. Nerve conduction measures in mild diabetic neuropathy in the Early Diabetes Intervention Trial: the effects of age, sex, type of diabetes, disease duration, and anthropometric factors. Tolrestat Study Group for the Early Diabetes Intervention Trial. Neurology 1996; 46: 85-91.
5. Albers JW, Kenny DJ, Brown M, et al. Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial. Ann Neurol 1995; 38: 869-880.
6. Malik RA, Veves A, Walker D, et al. Sural nerve fibre pathology in diabetic patients with mild neuropathy: relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology. Acta Neuropathol (Berl) 2001; 101: 367-374.
7. Verdugo R, Ochoa JL. Quantitative somatosensory thermotest. A key method for functional evaluation of small calibre afferent channels. Brain 1992; 115: 893-913.
8. Yarnitsky D, Ochoa JL. Warm and cold specific somatosensory systems. Psychophysical thresholds, reaction times and peripheral conduction velocities. Brain 1991; 114: 1819-1826.
9. Dyck PJ. Quantitative sensory testing: a consensus report from the peripheral neuropathy association. Neurology 1993; 43: 1050-1052.
10. Shy ME, Frohman EM, So YT, et al. Quantitative sensory testing: report of the therapeutics and technology assessment subcommittee of the American academy of neurology. Neurology 2003; 60: 898-904.
11. Shun CT, Chang YC, Wu HP, et al. Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. Brain 2004; 127: 1593-1605.
12. Dyck PJ, Dyck PJB, Larson TS, O'Brien PC, Velosa JA. Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group. Diabetes Care 2000; 23: 510-517.
13. American Diabetes Association. Report of the Expert committee on the diagnosis and classification of diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197.
14. Cornblath DR, Chaudhry V, Carter K, et al. Total neuropathy score: validation and reliability study. Neurology 1999; 53: 1660-1664.
15. Dyck PJ, Sherman WR, Hallcher LM, et al. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol 1980; 8: 590-596.
16. Sorensen L, Molyneaux L, Yue DK. The relationship among pain, sensory loss, and small nerve fibers in diabetes. Diabetes Care 2006; 29: 883-887.
17. Lin YH, Hsieh SC, Chao CC, Chang YC, Hsieh ST. Influence of aging on thermal and vibratory thresholds of quantitative sensory testing. J Peripher Nerv Syst 2005; 10: 269-281.
18. Lin YH, Huang MH, Chang YC, et al. Quantitative sensory testing: normative values and its application in diabetic neuropathy. Acta Neurol Taiwan 1998; 7: 176-184.
19. Pan CL, Lin YH, Lin WM, Tai TY, Hsieh ST. Degeneration of nociceptive nerve terminals in human peripheral neuropathy. Neuroreport 2001; 12: 787-792.
20. Pan CL, Tseng TJ, Lin YH, Chiang MC, Lin WM, Hsieh ST. Cutaneous innervation in Guillain-Barre syndrome: pathology and clinical correlations. Brain 2003; 126: 386-397.
21. Hagander LG, Midani HA, Kuskowski MA, Parry GJ. Quantitative sensory testing: effect of site and skin temperature on thermal thresholds. Clin Neurophysiol 2000; 111: 17-22.
22. Yarnitsky D, Sprecher E. Thermal testing: normative data and repeatability for various test algorithms. J Neurol Sci 1994; 125: 39-45.
23. Hadden RD, Cornblath DR, Hughes RA, et al. Electrophysiological classification of Guillain-Barre syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group. Ann Neurol 1998; 44: 780-788.
24. Pan CL, Yuki N, Koga M, Chiang MC, Hsieh ST. Acute sensory ataxic neuropathy associated with monospecific anti-GD1b IgG antibody. Neurology 2001; 57: 1316-1318.
25. Consensus Development Conference. Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Electrodiagnostic measures. Neurology 1992; 42: 1827-1829.
26. Dyck PJ, Karnes JL, Gillen DA, O'Brien PC, Zimmerman IR, Johnson DM. Comparison of algorithms of testing for use in automated evaluation of sensation. Neurology 1990; 40: 1607-1613.
27. Dyck PJ, Zimmerman I, Gillen DA, Johnson D, Karnes JL, O'Brien PC. Cool, warm, and heat-pain detection thresholds: testing methods and inferences about anatomic distribution of receptors. Neurology 1993; 43: 1500-1508.
28. Dyck PJ, Zimmerman IR, Johnson DM, et al. A standard test of heat-pain responses using CASE IV. J Neurol Sci 1996; 136: 54-63.
29. Tkac I, Bril V. Glycemic control is related to the electrophysiologic severity of diabetic peripheral sensorimotor polyneuropathy. Diabetes Care 1998; 21: 1749-1752.
30. Hagander LG, Midani HA, Kuskowski MA, Parry GJ. Quantitative sensory testing: effect of site and pressure on vibration thresholds. Clin Neurophysiol 2000; 111: 1066-1069.
31. Perkins BA, Greene DA, Bril V. Glycemic control is related to the morphological severity of diabetic serisorimotor polyneuropathy. Diabetes Care 2001; 24: 748-752.
32. Boulton AJ. Lowering the risk of neuropathy, foot ulcers and amputations. Diabet Med 1998; 15(Suppl. 4): S57-S59.
33. Pfeifer MA, Schumer MP. Clinical trials of diabetic neuropathy: past, present, and future. Diabetes 1995; 44:1355-1361.
34. The DCCT Research Group. Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). The DCCT Research Group. Diabetes 1988; 37: 476-481.
35. Boulton AJM, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: a statement by the American diabetes association. Diabetes Care 2005; 28: 956-962.
36. Consensus Development Conference. Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Quantitative sensory testing. Neurology 1992; 42: 1829-1831.
37. Magda P, Latov N, Renard MV, Sander HW. Quantitative sensory testing: high sensitivity in small fiber neuropathy with normal NCS/EMG. J Peripher Nerv Syst 2002; 7: 225-228.
38. The DCCT Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group. Ann Intern Med 1995; 122: 561-568.
39. The Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329: 977-986.